Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Biopool enters option agreement for assay technology

Jan. 13, 1997

Genzyme granted U.S. patent for mutation detection technology

Jan. 10, 1997

Four HY-TEC autoimmune test kits approved for U.S. marketing

Jan. 10, 1997

Cortecs launches Helisal One Step test in U.K.

Jan. 10, 1997

EchoGen submitted for European regulatory review

Jan. 9, 1997

FDA approves new HIV 1/2 test

Jan. 9, 1997

Digene seeks FDA marketing approval for cytomegalovirus test

Jan. 8, 1997

ATL technology approaches FDA approval

Jan. 7, 1997

Osaka University discloses new antigen for the detection of HIV-1

Jan. 7, 1997

Biofield seeks approval for new breast cancer diagnostic system

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.